Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01928459
Title Phase 1b Trial of BGJ398/BYL719 in Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | CAN | BEL | AUS

Facility Status City State Zip Country Details
H. Lee Moffitt Cancer Center & Research Institute Moffitt 4 Tampa Florida 33612 United States Details
University of Michigan Comprehensive Cancer Center SC Ann Arbor Michigan 48109-0944 United States Details
Karmanos Cancer Institute Dept of Onc Detroit Michigan 48201 United States Details
Washington University School of Medicine Onc Dept Saint Louis Missouri 63110 United States Details
Memorial Sloan Kettering Cancer Center Onc Dept New York New York 10065 United States Details
Vanderbilt University Medical Center Dept of Onc Nashville Tennessee 37232 United States Details
Cancer Therapy & Research Center / UT Health Science Center SC San Antonio Texas 78229 United States Details
Novartis Investigative Site Parkville Victoria 3050 Australia Details
Novartis Investigative Site Bruxelles 1200 Belgium Details
Novartis Investigative Site Toronto Ontario M5G 2M9 Canada Details
Novartis Investigative Site Lyon Cedex 69373 France Details
Novartis Investigative Site Saint Herblain cedex 44805 France Details
Novartis Investigative Site Koeln Nordrhein-Westfalen 50937 Germany Details
Novartis Investigative Site Milano MI 20141 Italy Details
Novartis Investigative Site Modena MO 41100 Italy Details
Novartis Investigative Site Seoul Korea 05505 Korea, Republic of Details
Novartis Investigative Site Amsterdam 1066 CX Netherlands Details
Novartis Investigative Site Singapore 169610 Singapore Details
Novartis Investigative Site Sevilla Andalucia 41013 Spain Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
Novartis Investigative Site Madrid 28050 Spain Details
Novartis Investigative Site Bellinzona 6500 Switzerland Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field